These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J. Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091 [Abstract] [Full Text] [Related]
4. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade). Kobelt G, Andlin-Sobocki P, Brophy S, Jönsson L, Calin A, Braun J. Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514 [Abstract] [Full Text] [Related]
5. [Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index]. Lacassagne L, Didier A, Doussau S, Murris-Espin M, Birot P, Charlet JP, Thach KS, Tiberge M, Paoli JR, Pessey JJ, Léophonte P. Rev Mal Respir; 2000 Apr; 17(2):467-74. PubMed ID: 10859765 [Abstract] [Full Text] [Related]
8. [Subjective well-being in obstructive sleep apnea syndrome before and after nCPAP therapy]. Hetzel C, Weess HG, Schröder A, Steinberg R. Wien Med Wochenschr; 1995 Apr; 145(17-18):510-1. PubMed ID: 8588390 [Abstract] [Full Text] [Related]
9. Effectiveness of multilevel (tongue and palate) radiofrequency tissue ablation for patients with obstructive sleep apnea syndrome. Steward DL. Laryngoscope; 2004 Dec; 114(12):2073-84. PubMed ID: 15564825 [Abstract] [Full Text] [Related]
10. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness. Sampol G, Rodés G, Romero O, Jurado MJ, Lloberes P. Respir Med; 2007 Mar; 101(3):461-6. PubMed ID: 16919928 [Abstract] [Full Text] [Related]
12. [Nasal CPAP therapy of obstructive sleep apnea syndrome with expiratory pressure reduction: a prospective randomized study of acceptance of treatment during therapy initiation]. Ficker JH, Müller D, Wiest G, Lehnert G, Dertinger SH, Katalinic A, Hahn EG. Pneumologie; 1997 Jun; 51(6):586-91. PubMed ID: 9333792 [Abstract] [Full Text] [Related]
13. [Improvement of health-related quality of life in patients with obstructive sleep apnea syndrome under CPAP therapy]. de Zeeuw J, Baberg HT, Kempkens DJ, Schmalz O, Duchna HW, Orth M, Kugler J, Schultze-Werninghaus G, Rasche K. Med Klin (Munich); 2003 Apr 15; 98(4):181-7. PubMed ID: 12715141 [Abstract] [Full Text] [Related]
14. Which derivative from overnight oximetry best predicts symptomatic response to nasal continuous positive airway pressure in patients with obstructive sleep apnoea? Choi S, Bennett LS, Mullins R, Davies RJ, Stradling JR. Respir Med; 2000 Sep 15; 94(9):895-9. PubMed ID: 11001083 [Abstract] [Full Text] [Related]